Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001003642-17-000043)

Filing Details

Accession Number:: 0001003642-17-000043
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-15 19:26:24
Reporting Period:: 2017-05-12

Filing Date:: 2017-05-15
Accepted Time:: 2017-05-15 19:26:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1003642	Impax Laboratories Inc	IPXL	Pharmaceutical Preparations (2834)	650403311

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1196063	Michael Nestor	C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544	President, Impax Specialty	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-05-12	700	$17.11	115,168	No	4	S	Direct
Common Stock	Disposition	2017-05-14	3,002	$17.65	112,166	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	F	Direct

Footnotes

These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Nestor's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.